This is an unedited manuscript accepted for publication and provided as an Article in Press for early access at the author’s request. The article will undergo copyediting, typesetting, and galley proof review before final publication. Please be aware that errors may be identified during production that could affect the content. All legal disclaimers of the journal apply.
Abhimanyu Chauhan,
Chakresh Kumar Jain,
Abstract
Major Depressive Disorder (MDD) is a prevalent neuropsychiatric disorder with limited treatment efficacy and significant side effects associated with conventional antidepressants. Recent studies have highlighted the role of mitogen-activated protein kinase 3 (MAPK3) in the mechanisms underlying MDD, positioning it as a potential target for the development of novel therapeutic drugs. In this study, we employed various computational approaches to explore natural compounds as viable alternatives to synthetic antidepressants. Researchers used several advanced methods—like molecular docking, ADMET analysis, molecular dynamics simulations, and binding energy calculations (MM-GBSA)—to study how these natural compounds interact with the MAPK3 protein. Out of all the compounds tested, Cannflavin A showed the strongest ability to bind with the target protein and had favorable pharmacokinetic properties, which is why it was chosen for more detailed study.
To gain deeper insight into its function, researchers conducted Gene Ontology (GO) enrichment and Protein-Protein Interaction (PPI) network analyses for MAPK3. The GO analysis revealed significant enrichment in biological processes such as the ERK1 and ERK2 cascade, thyroid gland development, lung morphogenesis, and positive regulation of miRNA maturation, reinforcing its involvement in cellular signaling and neurobiological pathways. The PPI analysis identified key interactions between MAPK3 and regulatory proteins such as MAP2K1, TP53, DUSP1, and FOS, suggesting its role in signal transduction, stress response, and neuronal activity.
A 200-nanosecond molecular dynamics simulation was conducted to analyze the behavior of the Cannflavin A-MAPK3 complex. Important structural measures—such as RMSF, RMSD, SASA, and radius of gyration (Rg)—confirmed that the complex was stable. Additionally, MM-GBSA analysis showed that it had strong binding free energy. When compared to standard antidepressants like Paroxetine and Amitriptyline, Cannflavin A was found to interact with key residues of the MAPK3 protein, suggesting it may have promising therapeutic potential. These findings highlight the promise of natural compounds in MDD treatment and provide a foundation for further in vivo and in vitro investigations toward the development of safer and more effective antidepressant therapies.
Keywords: Major Depressive Disorder (MDD) is a prevalent neuropsychiatric disorder with limited treatment efficacy and significant side effects associated with conventional antidepressants.
[This article belongs to International Journal of Bioinformatics and Computational Biology ]
Abhimanyu Chauhan, Chakresh Kumar Jain. Exploring the Role of MAPK3 in Major Depressive Disorder: Molecular Docking, Dynamics, and Binding Free Energy Analysis of Natural Compounds as Alternatives to Conventional Drugs. International Journal of Bioinformatics and Computational Biology. 2025; 03(02):-.
Abhimanyu Chauhan, Chakresh Kumar Jain. Exploring the Role of MAPK3 in Major Depressive Disorder: Molecular Docking, Dynamics, and Binding Free Energy Analysis of Natural Compounds as Alternatives to Conventional Drugs. International Journal of Bioinformatics and Computational Biology. 2025; 03(02):-. Available from: https://journals.stmjournals.com/ijbcb/article=2025/view=216483
References
1. Wang JQ, Mao L. The ERK pathway: molecular mechanisms and treatment of depression. Mol Neurobiol. 2019;56:6197–205. https://doi.org/10.1007/s12035-019-1524-3
2. World Health Organization. Depressive disorder (depression) [Internet]. [cited 2024 Mar 18]. Available from: https://www.who.int/news-room/fact-sheets/detail/depression
3. Cui L, Li S, Wang S, Wu X, Liu Y, Yu W, et al. Major depressive disorder: hypothesis, mechanism, prevention and treatment. Signal Transduct Target Ther. 2024;9:30. https://doi.org/10.1038/s41392-024-01738-y
4. Ormel J, Oldehinkel AJ, Nolen WA, Vollebergh W. Psychosocial disability before, during, and after a major depressive episode. Arch Gen Psychiatry. 2004;61:387. https://doi.org/10.1001/archpsyc.61.4.387
5. Lu Z, Gao F, Teng F, Tian X, Guan H, Li J, et al. Exploring the pathogenesis of depression and potential antidepressants through the integration of reverse network pharmacology, molecular docking, and molecular dynamics. Medicine (Baltimore). 2023;102:e35793. https://doi.org/10.1097/MD.0000000000035793
6. Volmat V, Pouysségur J. Spatiotemporal regulation of the p42/p44 MAPK pathway. Biol Cell. 2001;93:71–9. https://doi.org/10.1016/S0248-4900(01)01129-7
7. Suga H, Torruella G, Burger G, Brown MW, Ruiz-Trillo I. Earliest holozoan expansion of phosphotyrosine signaling. Mol Biol Evol. 2014;31:517–28. https://doi.org/10.1093/molbev/mst241
8. Mao L-M, Wang JQ. Synaptically localized mitogen-activated protein kinases: local substrates and regulation. Mol Neurobiol. 2016;53:6309–15. https://doi.org/10.1007/s12035-015-9535-1
9. Sweatt JD. Mitogen-activated protein kinases in synaptic plasticity and memory. Curr Opin Neurobiol. 2004;14:311–7. https://doi.org/10.1016/j.conb.2004.04.001
10. Thome J, Sakai N, Shin K-H, Steffen C, Zhang Y-J, Impey S, et al. cAMP response element-mediated gene transcription is upregulated by chronic antidepressant treatment. J Neurosci. 2000;20:4030–6. https://doi.org/10.1523/JNEUROSCI.20-11-04030.2000
11. Chauhan A, Jain CK. Exploring gene regulatory interaction networks and predicting therapeutic molecules among major depressive disorder and bipolar disorder: a bioinformatics approach. J Affect Disord. 2025 Jan 17;375:64–74. https://doi.org/10.1016/j.jad.2025.01.078
12. Dwivedi Y, Rizavi HS, Roberts RC, Conley RC, Tamminga CA, Pandey GN. Reduced activation and expression of ERK1/2 MAP kinase in the post‐mortem brain of depressed suicide subjects. J Neurochem. 2001;77:916–28. https://doi.org/10.1046/j.1471-4159.2001.00300.x
13. Fries GR, Saldana VA, Finnstein J, Rein T. Molecular pathways of major depressive disorder converge on the synapse. Mol Psychiatry. 2023;28:284–97. https://doi.org/10.1038/s41380-022-01806-1
14. Hirschfeld RM. History and evolution of the monoamine hypothesis of depression. J Clin Psychiatry. 2000;61 Suppl 6:4–6.
15. Abhimanyu, Jain CK. Computational interaction study of immunomodulatory plant derivatives against SARS-CoV-2 Mpro target. In: Swamy MK, Kumar A, editors. Phytochemical Genomics: Plant Metabolomics and Medicinal Plant Genomics. Singapore: Springer Nature Singapore; 2022. p. 681–98. https://doi.org/10.1007/978-981-19-5779-6_29
16. Taherkhani A, Khodadadi P, Samie L, Azadian Z, Bayat Z. Flavonoids as strong inhibitors of MAPK3: a computational drug discovery approach. Int J Anal Chem. 2023;2023:1–16. https://doi.org/10.1155/2023/8899240
17. Chandre R, Upadhyay BN, Murthy KHHVSSN. Clinical evaluation of Kushmanda Ghrita in the management of depressive illness. Ayu. 2011;32:230–3. https://doi.org/10.4103/0974-8520.92592
18. Ye B, Tian W, Wang B, Liang J. CASTpFold: Computed Atlas of Surface Topography of the universe of protein folds. Nucleic Acids Res. 2024;52:W194–9. https://doi.org/10.1093/nar/gkae415
19. Pires DEV, Blundell TL, Ascher DB. pkCSM: predicting small-molecule pharmacokinetic and toxicity properties using graph-based signatures. J Med Chem. 2015;58:4066–72. https://doi.org/10.1021/acs.jmedchem.5b00104
20. Daina A, Michielin O, Zoete V. SwissADME: a free web tool to evaluate pharmacokinetics, drug-likeness and medicinal chemistry friendliness of small molecules. Sci Rep. 2017;7:42717. https://doi.org/10.1038/srep42717
21. Valdés-Tresanco MS, Valdés-Tresanco ME, Valiente PA, Moreno E. gmx_MMPBSA: a new tool to perform end-state free energy calculations with GROMACS. J Chem Theory Comput. 2021;17:6281–91. https://doi.org/10.1021/acs.jctc.1c00645
22. von Mering C. STRING: a database of predicted functional associations between proteins. Nucleic Acids Res. 2003;31:258–61. https://doi.org/10.1093/nar/gkg034
| Volume | 03 |
| Issue | 02 |
| Received | 03/03/2025 |
| Accepted | 15/05/2025 |
| Published | 09/07/2025 |
| Publication Time | 128 Days |
PlumX Metrics